INUS
Straddle Chart

Markets / Mutual funds / Equity ETFs

Mutual fundsSIF

Aditya Birla Sun Life Nifty Healthcare ETF - Regular Plan - Growth

NAVs of 6 Nov 2026

Aditya Birla Sun Life Mutual Fund · Index & ETFs fund · Regular plan · Growth

Equity ETFsRegular · Growth
NAV · 5 Nov 2026
₹17.3036 ▲ 0.70%
Aditya Birla Sun Life Mutual Fund
Fund size₹81.44 crJuly - September 2026
1-month range₹15.83 – 17.30
1 year+14.24%rank 4 of 42
3 years+21.80%a year
5 years+15.00%a year

What the fund does

Index & ETFs fund in the Equity ETFs category, from Aditya Birla Sun Life Mutual Fund.

Fund houseAditya Birla Sun Life Mutual Fund

NAV history

161717 2026-08-112026-08-242026-09-042026-09-182026-10-012026-10-152026-10-29

Returns

1 week
+3.85%avg 5.0%
1 month
+4.44%avg 3.9%
3 months
+0.69%avg -1.9%
6 months
+9.48%avg -2.5%
This year
+15.24%avg -4.5%
1 year
+14.24%avg -2.6% · #4/42
3 years (a year)
+21.80%avg 9.6% · #4/29
5 years (a year)
+15.00%avg -6.6% · #2/18

Bars: this plan; the thin mark is the Equity ETFs average (regular plans, growth option). Over a year: yearly averages (CAGR). Past returns do not guarantee future returns. Information only, not investment advice.

Monthly returns (%)

YearJanFebMarAprMayJunJulAugSepOctNovDec
2024+4.0
2025-6.2-7.9+7.8+1.1+0.4+3.8+3.3-3.3-1.4+3.8+2.3-2.6
2026-5.1+7.2-4.5+5.0+3.2+4.9+4.0+1.1-4.8+1.9+2.2

Each month's change in NAV (the current month to the latest NAV).

What if you had invested?

Worked out from this plan's actual NAVs. SIP: invested on the first NAV of each month. Taxes and exit loads are not included. Past returns do not guarantee future returns. Information only, not investment advice.

Portfolio as on 30 Sept 2026

Stocks held2022 lines in all
Top 10 stocks75.9%of the fund
Short positions-0.7%sold through derivatives
Net equity99.3%long stocks and derivatives minus shorts

Where the money is

Equity 100.0%Short -0.7%

Sectors (stocks held)

Pharmaceuticals & Biotechnology
81.1%
Healthcare Services
18.9%

Changes since 31 Aug 2026

Share of fund30 Sept 202631 Aug 2026Change
Stocks held100.0%100.0%0.00
Short positions-0.7%0.0%-0.69
Cash & others0.0%0.0%0.00
Top 10 stocks75.9%77.3%-1.45
Number of stocks20200
New stocks 2
  • Gland Pharma Ltd.2.04%
  • Krishna Institute of Medical Sciences Ltd.1.76%
Stocks sold off 2
  • Piramal Pharma Ltd.was 1.15%
  • Syngene International Ltd.was 0.66%
Bought more 2
  • Dr. Reddy's Laboratories Ltd.+0.59
  • Laurus Labs Ltd.+0.40
Cut back 5
  • Sun Pharmaceutical Industries Ltd.-1.08
  • Max Healthcare Institute Ltd.-0.56
  • Fortis Healthcare Ltd.-0.52
  • Apollo Hospitals Enterprise Ltd.-0.42
  • Biocon Ltd.-0.25

Change is in percentage points. Bought more and cut back list stocks whose share of the fund moved by at least 0.25 points. A share can also move because the price changed, not only because the fund traded.

Stocks held 20

HoldingSector / type% of fund
Sun Pharmaceutical Industries Ltd.
INE044A01036		Pharmaceuticals & Biotechnology17.00%
Divi's Laboratories Ltd.
INE361B01024		Pharmaceuticals & Biotechnology10.46%
Apollo Hospitals Enterprise Ltd.
INE437A01024		Healthcare Services7.45%
Laurus Labs Ltd.
INE947Q01028		Pharmaceuticals & Biotechnology6.81%
Cipla Ltd.
INE059A01026		Pharmaceuticals & Biotechnology6.69%
Dr. Reddy's Laboratories Ltd.
INE089A01031		Pharmaceuticals & Biotechnology6.64%
Torrent Pharmaceuticals Ltd.
INE685A01028		Pharmaceuticals & Biotechnology6.26%
Max Healthcare Institute Ltd.
INE027H01010		Healthcare Services6.11%
Lupin Ltd.
INE326A01037		Pharmaceuticals & Biotechnology4.35%
Aurobindo Pharma Ltd.
INE406A01037		Pharmaceuticals & Biotechnology4.08%
Fortis Healthcare Ltd.
INE061F01013		Healthcare Services3.54%
Glenmark Pharmaceuticals Ltd.
INE935A01035		Pharmaceuticals & Biotechnology3.10%
Alkem Laboratories Ltd.
INE540L01014		Pharmaceuticals & Biotechnology2.77%
Zydus Lifesciences Ltd.
INE010B01027		Pharmaceuticals & Biotechnology2.54%
Mankind Pharma Ltd.
INE634S01028		Pharmaceuticals & Biotechnology2.50%
IPCA Laboratories Ltd.
INE571A01038		Pharmaceuticals & Biotechnology2.36%
Biocon Ltd.
INE376G01013		Pharmaceuticals & Biotechnology2.28%
Gland Pharma Ltd.
INE068V01023		Pharmaceuticals & Biotechnology2.04%
Krishna Institute of Medical Sciences Ltd.
INE967H01025		Healthcare Services1.76%
Abbott India Ltd.
INE358A01014		Pharmaceuticals & Biotechnology1.22%

Short positions 1

HoldingSector / type% of fund
Net Receivable / Payable–-0.69%

Debt, money market and cash 1

HoldingSector / type% of fund
TREPS–0.71%

From the fund house's monthly portfolio (mutualfund.adityabirlacapital.com), as on 30 Sept 2026. Percentages are of the fund's net assets; short positions are negative. Published about ten days after each month ends.

Risk

Volatility14.0%yearly, from daily NAVs
Worst fall-15.99%31 Dec 2021 → 30 Jun 2022

Volatility: how much the NAV moves, as a yearly figure (higher = bumpier). Worst fall: the biggest drop from a high, in the NAV history we hold (from 29 Oct 2021).

Fund details

Fund size (average AUM, July - September 2026)₹81.44 cr across all plans
Fund houseAditya Birla Sun Life Mutual Fund
CategoryIndex & ETFs · Equity ETFs
PlanRegular
OptionGrowth
Scheme code (AMFI)149262
ISININF209KB10C2
NAV date5 Nov 2026

Top Equity ETFs funds (regular plans)

Fund1 year3 years (a year)
Aditya Birla Sun Life Silver ETF+27.62%+37.09%
Aditya Birla Sun Life Gold ETF+18.58%+31.76%
Mirae Asset S&P 500 Top 50 ETF+6.40%+24.51%
Aditya Birla Sun Life Nifty Healthcare ETF+14.24%+21.80%
Axis NIFTY Healthcare ETF+14.04%+21.39%
Mirae Asset Nifty India Manufacturing ETF+4.16%+18.53%
Aditya Birla Sun Life Nifty Next 50 ETF+3.21%+17.89%
Mirae Asset Nifty Next 50 ETF+3.17%+17.82%

All Equity ETFs funds ranked › · Compare with others ›

← All mutual funds

Information only, not investment advice.

What is the NAV of Aditya Birla Sun Life Nifty Healthcare ETF - Regular Plan - Growth today?

₹17.3036 as of 5 Nov 2026, from AMFI's official NAV data.

What are the returns of Aditya Birla Sun Life Nifty Healthcare ETF - Regular Plan - Growth?

1 year: 14.24%, 3 years: 21.80% a year, 5 years: 15.00% a year

How does Aditya Birla Sun Life Nifty Healthcare ETF rank in its category?

4 of 42 Equity ETFs funds (regular plans, growth option) by 1-year return.

What is the difference between direct and regular plans?

Both invest in the same portfolio. Direct plans are bought straight from the fund house and pay no distributor commission, so their expenses are lower and their NAV grows slightly faster.